🇺🇸 FDA
Pipeline program

[177Lu]Lu-XT117

XT-XTR017-1-01 V1.3

Phase 1 small_molecule active

Quick answer

[177Lu]Lu-XT117 for Advanced Solid Tumor is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Advanced Solid Tumor
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials